The Island of Bermuda provides a unique opportunity for studying hereditary breast and ovarian cancer. The island has a population of 60,000 with only 1% immigration and emigration per year. The island is served by a single hospital and has a single tumor registry. Over the course of the last three years, we have collected family histories of patients with breast or ovarian cancer diagnosed since 1980. We are currently in the process of analyzing this data to determine the incidence of hereditary breast and ovarian cancer on the island and to develop ways of identifying and notifying those families who are high risk.

If you would like additional information on the Breast/Ovarian Cancer Genetics and Risk Assessment Program at the Massachusetts General Hospital Cancer Center, please contact:
Connie Roche at 617-726-4919

Kevin S. Hughes, MD
Assistant Professor of Surgery, Harvard Medical School
Surgical Director, Breast Screening
Clinical Co-Director, Breast/Ovarian Cancer Genetics and Risk Assessment Program
Division of Surgical Oncology, Massachusetts General Hospital

Connie A. Roche, MSN, RN, CS
Division of Surgical Oncology, Massachusetts General Hospital
Nurse Practitioner, Avon Foundation Comprehensive Breast Evaluation Center
Nurse Practitioner, Breast and Ovarian Cancer Genetics and Risk Assessment Program